Understanding how cells control protein breakdown and RNA for health
Superchanneling, Regulation of Caspases, and Site-Specific Control of RNA
This work explores how our cells manage and break down proteins, a process vital for preventing diseases like cancer and neurodegeneration.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | California Institute of Technology NIH-funded |
| Lab location | 1 site (Pasadena, United States) |
| Project ID | NIH-11179119 on NIH RePORTER |
What this research studies
Our bodies constantly break down and recycle proteins, a process called proteolysis, which is essential for keeping us healthy. This project focuses on a key system, the ubiquitin-proteasome system, and specific pathways that recognize and target proteins for breakdown. By understanding these fundamental cellular processes, we can learn why they sometimes go wrong in diseases like cancer, neurodegeneration, and immune disorders. This research specifically looks into new aspects of how certain signals on proteins direct their breakdown and how this might connect to other important cell functions.
Who could benefit from this research
Good fit: This foundational work is relevant to patients with conditions such as cancer, neurodegenerative diseases, cardiovascular syndromes, and immune disorders, where protein regulation plays a critical role.
Not a fit: Patients seeking immediate direct clinical intervention or treatment may not find direct benefit from this basic science research.
Why it matters
Potential benefit: If successful, this fundamental understanding could pave the way for new treatments that target protein breakdown pathways to address a wide range of human diseases.
How similar studies have performed: This research builds upon over three decades of successful studies in the field, indicating a strong foundation and established expertise.
Where this research is happening
Pasadena, United States
- California Institute of Technology — Pasadena, United States (Active)
Researchers
- Principal investigator: Varshavsky, Alexander J — California Institute of Technology
- Study coordinator: Varshavsky, Alexander J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.